Julen
Oyarzabal Santamarina
Investigador hasta 2018
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (2)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2009
-
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
Oncogene, Vol. 28, Núm. 6, pp. 781-791